EUPRESSYL

Eupressyl Adverse Events Reported to the FDA Over Time

How are Eupressyl adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Eupressyl, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Eupressyl is flagged as the suspect drug causing the adverse event.

Most Common Eupressyl Adverse Events Reported to the FDA

What are the most common Eupressyl adverse events reported to the FDA?

Fall	34 (4.03%)
Hypotension	27 (3.2%)
Anaemia	26 (3.08%)
Cytolytic Hepatitis	24 (2.84%)
Renal Failure	22 (2.61%)
Thrombocytopenia	21 (2.49%)
Renal Impairment	17 (2.01%)
Dizziness	15 (1.78%)
Cholestasis	14 (1.66%)
Hyponatraemia	12 (1.42%)
Pancreatitis Acute	12 (1.42%)
	Show More
Nephropathy	11 (1.3%)
Orthostatic Hypotension	11 (1.3%)
Sudden Death	11 (1.3%)
Cerebral Haematoma	10 (1.18%)
Drug Rash With Eosinophilia And Sys...	10 (1.18%)
Pruritus	10 (1.18%)
Tubulointerstitial Nephritis	10 (1.18%)
Condition Aggravated	8 (.95%)
Dyspnoea	8 (.95%)
Pain	8 (.95%)
Haemoglobin Decreased	7 (.83%)
Hyperkalaemia	7 (.83%)
Malaise	7 (.83%)
Rash Maculo-papular	7 (.83%)
Renal Failure Acute	7 (.83%)
Sepsis	7 (.83%)
Vascular Purpura	7 (.83%)
Venous Insufficiency	7 (.83%)
Cardio-respiratory Arrest	6 (.71%)
Drug Interaction	6 (.71%)
Gamma-glutamyltransferase Increased	6 (.71%)
General Physical Health Deteriorati...	6 (.71%)
Hepatitis	6 (.71%)
Hypokalaemia	6 (.71%)
International Normalised Ratio Incr...	6 (.71%)
Leukocytoclastic Vasculitis	6 (.71%)
Atrial Fibrillation	5 (.59%)
Blood Creatinine Increased	5 (.59%)
Depression	5 (.59%)
Disorientation	5 (.59%)
Eosinophilia	5 (.59%)
Guillain-barre Syndrome	5 (.59%)
Head Injury	5 (.59%)
Hydrocephalus	5 (.59%)
Hypertension	5 (.59%)
Hyperthermia	5 (.59%)
Joint Injury	5 (.59%)
Nausea	5 (.59%)
Oedema Peripheral	5 (.59%)
Pyrexia	5 (.59%)
Ventricular Arrhythmia	5 (.59%)
Wrist Fracture	5 (.59%)
Asthenia	4 (.47%)
Blood Alkaline Phosphatase Increase...	4 (.47%)
Bronchospasm	4 (.47%)
Cerebrovascular Accident	4 (.47%)
Colitis Ischaemic	4 (.47%)
Dermatitis Bullous	4 (.47%)
Headache	4 (.47%)
Pulmonary Oedema	4 (.47%)
Red Blood Cell Count Decreased	4 (.47%)
Tuberculosis	4 (.47%)
Acute Hepatic Failure	3 (.36%)
Aortic Dissection	3 (.36%)
Bacterial Test Positive	3 (.36%)
Blood Urea Increased	3 (.36%)
Cardiac Arrest	3 (.36%)
Cardiac Murmur Functional	3 (.36%)
Cerebral Ischaemia	3 (.36%)
Confusional State	3 (.36%)
Device Related Infection	3 (.36%)
Ecchymosis	3 (.36%)
Haematoma	3 (.36%)
Loss Of Consciousness	3 (.36%)
Lung Disorder	3 (.36%)
Mental Impairment	3 (.36%)
Priapism	3 (.36%)
Sarcoidosis	3 (.36%)
Seasonal Allergy	3 (.36%)
Septic Shock	3 (.36%)
Skin Lesion	3 (.36%)
Toxic Skin Eruption	3 (.36%)
Urinary Retention	3 (.36%)
Abdominal Pain Upper	2 (.24%)
Acute Generalised Exanthematous Pus...	2 (.24%)
Agranulocytosis	2 (.24%)
Aortic Bruit	2 (.24%)
Aortic Dilatation	2 (.24%)
Back Pain	2 (.24%)
Blood Pressure Increased	2 (.24%)
Bradycardia	2 (.24%)
Bronchiolitis	2 (.24%)
Coma	2 (.24%)
Decreased Appetite	2 (.24%)
Dehydration	2 (.24%)
Depressed Level Of Consciousness	2 (.24%)
Diarrhoea	2 (.24%)
Diffuse Alveolar Damage	2 (.24%)
Electrocardiogram Abnormal	2 (.24%)
Electrocardiogram Qrs Complex Prolo...	2 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Eupressyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Eupressyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Eupressyl

What are the most common Eupressyl adverse events reported to the FDA?

Hepatic And Hepatobiliary	50 (5.92%)
Renal Disorders	49 (5.81%)
Epidermal And Dermal Conditions	48 (5.69%)
Injuries	47 (5.57%)
Decreased And Nonspecific Blood Pre...	40 (4.74%)
Neurological	34 (4.03%)
Cardiac Arrhythmias	29 (3.44%)
Electrolyte And Fluid Balance Condi...	28 (3.32%)
Anemias Nonhemolytic And Marrow Dep...	27 (3.2%)
Platelet	23 (2.73%)
Nephropathies	22 (2.61%)
	Show More
Infections - Pathogen Unspecified	21 (2.49%)
Hematology Investigations	20 (2.37%)
Central Nervous System Vascular	18 (2.13%)
Skin Vascular Abnormalities	17 (2.01%)
Cardiac And Vascular Investigations	15 (1.78%)
Exocrine Pancreas Conditions	15 (1.78%)
Respiratory	14 (1.66%)
Bone And Joint Injuries	12 (1.42%)
Fatal Outcomes	12 (1.42%)
Bacterial Infectious	11 (1.3%)
Renal And Urinary Tract Investigati...	11 (1.3%)
White Blood Cell	11 (1.3%)
Body Temperature Conditions	10 (1.18%)
Vascular Hypertensive	9 (1.07%)
Arteriosclerosis, Stenosis, Vascula...	8 (.95%)
Deliria	8 (.95%)
Gastrointestinal Signs	8 (.95%)
Lower Respiratory Tract Disorders	8 (.95%)
Peripheral Neuropathies	7 (.83%)
Therapeutic And Nontherapeutic Effe...	7 (.83%)
Enzyme	6 (.71%)
Hepatobiliary	6 (.71%)
Allergic Conditions	5 (.59%)
Depressed Mood Disorders	5 (.59%)
Increased Intracranial Pressure And...	5 (.59%)
Urinary Tract Signs	5 (.59%)
Bronchial Disorders	4 (.47%)
Gastrointestinal Inflammatory Condi...	4 (.47%)
Headaches	4 (.47%)
Mental Impairment	4 (.47%)
Mycobacterial Infectious	4 (.47%)
Vascular	4 (.47%)
Aneurysms And Artery Dissections	3 (.36%)
Embolism And Thrombosis	3 (.36%)
Glucose Metabolism Disorders	3 (.36%)
Immune	3 (.36%)
Medication Errors	3 (.36%)
Microbiology And Serology	3 (.36%)
Movement Disorders	3 (.36%)
Muscle	3 (.36%)
Musculoskeletal And Connective Tiss...	3 (.36%)
Procedural And Device Related Injur...	3 (.36%)
Sexual Function And Fertility	3 (.36%)
Therapeutic Procedures And Supporti...	3 (.36%)
Vascular Hemorrhagic	3 (.36%)
Anxiety Disorders	2 (.24%)
Appetite And General Nutritional	2 (.24%)
Bone And Joint Therapeutic Procedur...	2 (.24%)
Cardiac Valve	2 (.24%)
Dental And Gingival Conditions	2 (.24%)
Encephalopathies	2 (.24%)
Fungal Infectious	2 (.24%)
Gastrointestinal Motility And Defec...	2 (.24%)
Heart Failures	2 (.24%)
Hematological And Lymphoid Tissue T...	2 (.24%)
Metabolic, Nutritional And Blood Ga...	2 (.24%)
Pulmonary Vascular	2 (.24%)
Seizures	2 (.24%)
Skin Appendage Conditions	2 (.24%)
Tissue	2 (.24%)
Viral Infectious	2 (.24%)
Water, Electrolyte And Mineral	2 (.24%)
Acid-base	1 (.12%)
Autoimmune	1 (.12%)
Bladder And Bladder Neck Disorders	1 (.12%)
Bone Disorders	1 (.12%)
Bone, Calcium, Magnesium And Phosph...	1 (.12%)
Cardiac Therapeutic Procedures	1 (.12%)
Chemical Injury And Poisoning	1 (.12%)
Coronary Artery	1 (.12%)
Dementia And Amnestic Conditions	1 (.12%)
Disturbances In Thinking	1 (.12%)
Eye	1 (.12%)
Fetal Complications	1 (.12%)
Hypothalamus And Pituitary Gland	1 (.12%)
Inner Ear And Viiith Cranial Nerve	1 (.12%)
Joint	1 (.12%)
Neonatal And Perinatal Conditions	1 (.12%)
Obstetric And Gynecological Therape...	1 (.12%)
Ocular Sensory Symptoms	1 (.12%)
Pericardial	1 (.12%)
Pleural	1 (.12%)
Protein And Amino Acid Metabolism	1 (.12%)
Protein And Chemistry Analyses	1 (.12%)
Sleep Disorders	1 (.12%)
Spleen, Lymphatic And Reticulendoth...	1 (.12%)
Thyroid Gland	1 (.12%)
Tongue Conditions	1 (.12%)
Toxicology And Therapeutic Drug Mon...	1 (.12%)
Vision	1 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Eupressyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Eupressyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.